[
    [
        {
            "time": "",
            "original_text": "医药行业周报：CXO及创新药板块短期受事件因素扰动 赛道性性价比逐渐突出",
            "features": {
                "keywords": [
                    "医药行业",
                    "CXO",
                    "创新药",
                    "短期",
                    "事件因素",
                    "性价比"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业周报：CXO及创新药板块短期受事件因素扰动 赛道性性价比逐渐突出",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "中信建投：持续看好创新药国际化及CDMO长期竞争力",
            "features": {
                "keywords": [
                    "中信建投",
                    "创新药",
                    "国际化",
                    "CDMO",
                    "长期竞争力"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "中信建投：持续看好创新药国际化及CDMO长期竞争力",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "CRO产业进入爆发期，制药装备企业也抓住机遇积极布局",
            "features": {
                "keywords": [
                    "CRO",
                    "产业",
                    "爆发期",
                    "制药装备",
                    "机遇",
                    "布局"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "装备制造"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "CRO产业进入爆发期，制药装备企业也抓住机遇积极布局",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]